Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Allergence
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Allergence
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Emerging Therapy
Advisory
Advocacy
Allergen Strategies
Allergence
Allergy-Friendly Products
Appeal
Correction
Coupons, Giveaways & Deals
Editorial
Emerging Technology
Emerging Therapy
Food Allergy Advocacy
Legislation
Manufacturer Partnership
Media Coverage
New Product Announcements
News Coverage
Newsletter Archive
Parenting Strategies
Press Releases
Product Labeling
Product Previews
Product Safety
push
Resource Highlight
Safe Snack Guide
School Tools
Site
Social Media
Sponsored
Study
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Emerging Therapy
FDA Approves Dupixent® as First Biologic for Treatment of Children Aged...
News Wire ~ 3rd Party Press Release
-
2020/05/28
Emerging Therapy
Allerdent Enables Patients to Maintain Seasonal Allergy Immunotherapy During COVID-19 Pandemic
News Wire ~ 3rd Party Press Release
-
2020/05/06
Emerging Therapy
Oral Immunotherapy: What You Should Know, and What’s New (Webinar)
Dave Bloom
-
2020/04/30
Emerging Therapy
Pending Litigation Shows Food Allergy Treatments in Development are Sometimes Overhyped
Dave Bloom
-
2020/04/24
Emerging Therapy
BlueWillow Completes Preclinical Studies of Intranasal Peanut Allergy Vaccine
Dave Bloom
-
2020/04/03
Emerging Therapy
FDA Has Questions About Viaskin Peanut Efficacy, Delays Meeting with DBV...
Dave Bloom
-
2020/03/17
Emerging Therapy
ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...
News Wire ~ 3rd Party Press Release
-
2020/03/02
Emerging Therapy
FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment...
News Wire ~ 3rd Party Press Release
-
2020/02/22
Emerging Therapy
Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...
News Wire ~ 3rd Party Press Release
-
2020/02/21
Emerging Therapy
End Allergies Together Announces Winners of $1 Million Grand Challenge to...
News Wire ~ 3rd Party Press Release
-
2020/02/12
1
2
3
4
...
15
Page 3 of 15